Moreover, the expression level of survivin-2B/survivin in stage III and IV colorectal cancer was lower than that in stage I and II tumors [53], and reduced survivin-2B mRNA expression has been associated with colorectal cancer in the advanced pT stages [54]. This evidence concerns the gene BIRC5 and colorectal cancer.